We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+13.94%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$22.7B
AUM Growth
+$6.91B
Cap. Flow
+$4.55B
Cap. Flow %
20.03%
Top 10 Hldgs %
42.56%
Holding
3,800
New
1,351
Increased
647
Reduced
509
Closed
1,292

Sector Composition

Rank Sector Weight
1 Financials 8.27%
2 Industrials 7.89%
3 Technology 6.89%
4 Healthcare 4.69%
5 Communication Services 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKX icon
2101
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$657M
$179K ﹤0.01%
+15,229
New +$181K
ULBI icon
2102
Ultralife
ULBI
$105M
$175K ﹤0.01%
+19,497
New +$116K
YSG
2103
Yatsen Holding
YSG
$317M
$175K ﹤0.01%
+18,184
New +$104K
NAK
2104
Northern Dynasty Minerals
NAK
$953M
$174K ﹤0.01%
130,589
-90,296
-41% -$101K
ACRV icon
2105
Acrivon Therapeutics
ACRV
$74.5M
$173K ﹤0.01%
+145,895
New +$200K
SPCE icon
2106
Virgin Galactic
SPCE
$401M
$173K ﹤0.01%
+63,643
New +$195K
LIEN
2107
Chicago Atlantic BDC
LIEN
$216M
$173K ﹤0.01%
+16,763
New +$173K
CCIX
2108
DELISTED
Churchill Capital Corp IX
CCIX
$172K ﹤0.01%
+16,439
New +$179K
FLNA
2109
Filana Therapeutics
FLNA
$47.4M
$171K ﹤0.01%
+94,855
New +$169K
EWZS icon
2110
iShares MSCI Brazil Small-Cap ETF
EWZS
$220M
$169K ﹤0.01%
+12,796
New +$155K
PSBD icon
2111
Palmer Square Capital BDC
PSBD
$320M
$167K ﹤0.01%
11,966
-21,314
-64% -$288K
CHAU icon
2112
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$95.3M
$166K ﹤0.01%
+11,270
New +$156K
PSEC icon
2113
Prospect Capital
PSEC
$1.15B
$166K ﹤0.01%
52,484
-307,109
-85% -$1.07M
TBLA icon
2114
Taboola.com
TBLA
$1.11B
$166K ﹤0.01%
+45,390
New +$148K
OPRX icon
2115
OptimizeRx
OPRX
$131M
$164K ﹤0.01%
+12,201
New +$133K
GPMT
2116
Granite Point Mortgage Trust
GPMT
$60.7M
$163K ﹤0.01%
+66,217
New +$149K
FDMT icon
2117
4D Molecular Therapeutics
FDMT
$555M
$162K ﹤0.01%
43,903
-6,497
-13% -$22.8K
GALT icon
2118
Galectin Therapeutics
GALT
$218M
$162K ﹤0.01%
+77,200
New +$115K
KFII
2119
K&F Growth Acquisition Corp II
KFII
$417M
$161K ﹤0.01%
15,900
-12,105
-43% -$122K
TLS icon
2120
Telos
TLS
$350M
$160K ﹤0.01%
+50,526
New +$131K
ADUR
2121
Aduro Clean Technologies
ADUR
$560M
$160K ﹤0.01%
+17,928
New +$123K
CDLX icon
2122
Cardlytics
CDLX
$21.2M
$159K ﹤0.01%
+9,683
New +$167K
CIGL
2123
Concorde International Group
CIGL
$142M
$159K ﹤0.01%
+10,869
New +$67.5K
CMPX icon
2124
Compass Therapeutics
CMPX
$384M
$158K ﹤0.01%
+60,778
New +$125K
PRME icon
2125
Prime Medicine
PRME
$545M
$158K ﹤0.01%
+64,167
New +$98.9K

Similar funds

HRT Financial's Q2 2025 Portfolio in Review

As of Q2 2025, HRT Financial held 3,800 positions worth $22.7B, up 44% from $15.8B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

HRT Financial deployed $4.55B of net new capital in Q2 2025, opening 1,351 new positions and adding to 647 existing holdings. Its largest new stake was The AZEK Co: 2,834,659 shares worth $154M.

By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 8.3% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $430M trimmed.

  • HRT Financial's largest Q2 2025 buy was The AZEK Co: 2,834,659 shares worth $154M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $1.95B increase.
  • HRT Financial's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $430M.
  • HRT Financial fully exited Broadcom in Q2 2025, selling an estimated $443M.
  • HRT Financial's ten largest holdings make up 43% of its $22.7B portfolio in Q2 2025.
  • HRT Financial opened 1,351 new positions and closed 1,292 in Q2 2025.
  • HRT Financial's portfolio value rose 44% quarter-over-quarter to $22.7B.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.